Hypermarcas (OTCMKTS:HYPMY - Get Free Report) shares shot up 10% during mid-day trading on Wednesday . The company traded as high as $4.95 and last traded at $4.95. 102 shares were traded during trading, a decline of 99% from the average session volume of 17,428 shares. The stock had previously closed at $4.50.
Hypermarcas Trading Up 5.4%
The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.80 and a current ratio of 1.26. The stock has a market cap of $3.07 billion, a P/E ratio of 20.21 and a beta of 0.79. The stock has a 50-day moving average price of $4.33 and a 200-day moving average price of $3.61.
Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last released its earnings results on Wednesday, April 23rd. The company reported ($0.04) EPS for the quarter. Hypermarcas had a net margin of 12.51% and a return on equity of 6.95%. The firm had revenue of $184.34 million during the quarter.
Hypermarcas Announces Dividend
The company also recently disclosed a dividend, which will be paid on Friday, January 8th. Investors of record on Tuesday, July 1st will be issued a dividend of $0.0345 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a dividend yield of 2.81%. Hypermarcas's dividend payout ratio is 45.83%.
Hypermarcas Company Profile
(
Get Free Report)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Read More
Before you consider Hypermarcas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.
While Hypermarcas currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
